Johnson & Johnson Enterprise Innovation Inc. clinical trials
A subsidiary of Johnson & Johnson
The registry lists 7 studies whose lead sponsor is Johnson & Johnson Enterprise Innovation Inc.. 5 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 25, 2026.
Registry sponsor names on this page
- Johnson & Johnson Enterprise Innovation Inc.7 studies
Something wrong with this grouping? Tell us on the Johnson & Johnson page.
Studies
Recruiting first, then most recently updated. Showing 7 of 7. All Johnson & Johnson studies →
- JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCCRecruitingNCT04892173Phase 3
Sponsor listed in the registry: Johnson & Johnson Enterprise Innovation Inc.
- A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)RecruitingNCT06667908Phase 2
Sponsor listed in the registry: Johnson & Johnson Enterprise Innovation Inc.
- A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid TumorsRecruitingNCT06311578Phase 1
Sponsor listed in the registry: Johnson & Johnson Enterprise Innovation Inc.
- A Study of JNJ-1761981 in Participants With Solid TumorsRecruitingNCT07525141Phase 1
Sponsor listed in the registry: Johnson & Johnson Enterprise Innovation Inc.
- A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell CarcinomaRecruitingNCT07219212Phase 1
Sponsor listed in the registry: Johnson & Johnson Enterprise Innovation Inc.
- A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung CancerActive, not recruitingNCT06116786Phase 1
Sponsor listed in the registry: Johnson & Johnson Enterprise Innovation Inc.
- Confocal Laser Endomicroscopy Nodule Localization by Robotic BronchoscopyCompletedNCT05231278Not applicable
Sponsor listed in the registry: Johnson & Johnson Enterprise Innovation Inc.